1k a QUARTER is not good growth, especially for a new drug that is supposedly better than other drugs selling 6X more. 15% market share? 2.5 years into launch? That is not impressive. Lovaza still DOMINATES Vascepa.
They may have something at stake, but keep in mind they already cashed in millions of dollars in the teens due to Joe Z lies and pumps. They already made themselves mega rich. They are now playing with house money, so to risk it isn't a big deal to them. They already won this game.
what are you talking about? I am saying if Reduce-it is stopped at interim it will be $15, and if it isn't it will be $0. No one knows the real chance it gets stopped at interim. In the end, it's a drug trial, and drug trial results are not predictable. My point is that AMRN management could guarantee shareholders a nice return, instead of deciding to risk it ALL on interim reduce-it. Sure, perhaps that would involve giving up some potential upside, but it provides great immunization to disaster. Being greedy is a deadly sin for a reason.
Cause, ugh, they have mounts of debt and Marine scripts will never be high enough to pay back debt and also pay for operations?? If Reduce-it isn't stopped at interim, it is likely the trial will not be successful. And so the Anchor population will never be reached. Sure, maybe it could go to completion and show some very minor benefit, but that won't be enough to get people excited and sales up. If it's going to show a meaningful benefit, interim will tell us. And oh, if isn't stopped at interim, dilution is a 100% guarantee.
But you do realize that if Reduce-It isn't stopped at interim, this company will go BK and the stock go to $0, right? This is not a viable company unless Reduce-it is stopped at interim. There is thing called risk management, and AMRN management is not interested in that. They are fine risking EVERYTHING on interim Reduce-it. Let me ask you this, if there was a 50% chance you got $15, and a 50% you got $0, and I offered you $10 right now, would you take it?
haha....all cause of SR??!!! Oh my, he's back!! Good ole SR, the pumper who was not once right about any of the crazy things he use to say.
But yeah, no chance on buyout. Management thinks they are worth billions. And apparently they have never heard of the concept of a CVR (ie a way to de-risk this a little for shareholders and not make interim Reduce-It a 100% company riding event).
Man, SR is back. That is some funny stuff.
Well Joe Z told us years ago it was "much ado about nothing"!! And yet everyone claimed how important it was and even AMRN believe it was SO important. Why is the CEO telling us it's nothing?? Just a weird situation here.
And yeah, Marine sales are absolutely atrocious. Even today, people claiming the scripts were "great!" because they went up a couple of hundred. They've been in the low 12,000s for many many weeks now and people think this is GOOD?
Why does AMRN REFUSE to partner with a legitimate sales force??!!! They are just do everything the can to NOT sell this drug. People are now claiming that a $90m run rate is great. Um...what?
People are tired of if this, if that. They want real substantive news. Real earnings, real revenue growth, a real partnership, etc.
Yep. Only AMRN. Article comes out stating the FDA will not appeal...i.e. NCE is now ensured. And then AMRN plummets. Only this stock. Only this company. Absolute cursed company.
Let me also add that Joe Z and his past is VERY VERY relevant to this situation. If he had been fired and was gone and had no affiliation with AMRN any longer, I would agree with you. But Joe Z sits on the board, Joe Z is still getting free shares, and most importantly, if there are any negotiations going on, JOE Z is front and center in the room. STILL. So his voice is far from gone. He is still a major player in all decision being made! So his past, his rhetoric, and his mistakes are extremely important.
They are a generic drug company! Those companies do anything that is remotely possible for making even a single $. Taking a shot in the dark at something? Of course! That is wwhat generic drug companies do! There is no conspiracy!
The world is not out to get AMRN. You people and your "back door agreements" and "conspiracies". Joe Z burned a lot of bridges, that is the cause of most of this. His arrogance and haughty attitude towards the FDA and other BP is what caused the hostility. He made one of the worst decision in biotech history to GIA. In doing so, he decided to put everything at risk, and look at what has happened since. He thought he was gonna take on the world and prevail. News shock dude, this is a wicked game.
Well, it IS expected to be $350m in 2016! Sure, it's worth $13 billion!
How in the world is that a 13b company??!!
If only Joe Z would have done the right thing and made this company someone else's problem back in 2012 for $15-$20 a share. One of the worst decision in biotech history to GIA.
Even if Reduce-it is successful, approval probably isn't gonna happen until late 2018 or 2019. Which is like 1-2 years away from when generics can enter. Not much value in 1-2 years of an indication.